![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Neose, BioGeneriX Enter Protein Pact
Neose, BioGeneriX Enter Protein Pact
Neose Technologies has signed an agreement giving BioGeneriX AG an option to license its GlycoPEGylation technology. The total potential value of the deal wasn't disclosed in a press release by Neose. The biopharmaceutical company did say, however, that it includes milestones worth up to $61.5 million and unspecified upfront payments and royalties. The agreement aims to use the Neose technology to develop a "long-acting, next generation version of a currently marketed therapeutic protein," according to Neose.
iWon
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct